Literature DB >> 29667943

Factors Associated With Initiation of Biologics in Patients With Axial Spondyloarthritis in an Urban Asian City: A PRESPOND Study.

Wan Yu Png, Yu Heng Kwan1, Yi Xuan Lee, Ka Keat Lim1, Eng Hui Chew, Nai Lee Lui2, Chuen Seng Tan3, Julian Thumboo, Truls Østbye1, Warren Fong.   

Abstract

OBJECTIVE: The aim of this study was to examine if patients' sociodemographic, clinical characteristics, and patient-reported outcomes were associated with biologics initiation in patients with axial spondyloarthritis in Singapore.
METHODS: Data from a dedicated registry from a tertiary referral center in Singapore from January 2011 to July 2016 were used. Initiation of first biologics was the main outcome of interest. Logistic regression analyses were used to explore the association of various factors on biologics initiation.
RESULTS: Of 189 eligible patients (aged 37.7 ± 13.3 years; 76.2% were males), 30 (15.9 %) were started on biologics during follow-up. In the multivariable analysis model, age (odds ratio [OR]; 0.93; 95% confidence interval [CI], 0.89-0.98; p < 0.01), mental component summary score of Short-Form 36 Health Survey (OR, 0.18; 95% CI, 0.03-0.89; p = 0.04), erythrocyte sedimentation rate (OR, 1.02; 95% CI, 1.00-1.04; p = 0.02), presence of peptic ulcer disease (OR, 10.4; 95% CI, 2.21-48.8; p < 0.01), and lack of good response to nonsteroidal anti-inflammatory drugs (OR, 4.44; 95% CI, 1.63-12.1; p < 0.01) were found to be associated with biologics initiation.
CONCLUSIONS: Age, erythrocyte sedimentation rate, mental component summary score, comorbidities of peptic ulcer disease, and responsiveness to nonsteroidal anti-inflammatory drugs were associated with biologics initiation. It is essential that clinicians recognize these factors in order to optimize therapy.

Entities:  

Year:  2019        PMID: 29667943     DOI: 10.1097/RHU.0000000000000762

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  3 in total

1.  Are extra-spinal symptoms associated with quality of life in patients with axial spondyloarthritis? A 1-year follow-up study.

Authors:  Yu Heng Kwan; Warren Fong; Ying Ying Leung; Nai Lee Lui; Chuen Seng Tan; Rahul Malhotra; Truls Østbye; Julian Thumboo
Journal:  Clin Rheumatol       Date:  2019-03-23       Impact factor: 2.980

2.  Risk of malignancies in patients with spondyloarthritis treated with biologics compared with those treated with non-biologics: a systematic review and meta-analysis.

Authors:  Yu Heng Kwan; Ka Keat Lim; Warren Fong; Hendra Goh; Linkai Ng; Benjamin Haaland; Jie Kie Phang; Lian Leng Low; Joo Guan Yeo; Feng Huang; Ying Ying Leung; Julian Thumboo; Truls Østbye
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-05-28       Impact factor: 5.346

3.  Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis.

Authors:  Sizheng Steven Zhao; Selina Robertson; Tzvi Reich; Nicolas L Harrison; Robert J Moots; Nicola J Goodson
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.